Down-regulation of heme oxygenase-2 is associated with the increased expression of heme oxygenase-1 in human cell lines. 2006

Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
Department of Molecular Biology and Applied Physiology, Tohoku University School of Medicine, Sendai, Japan.

Intracellular heme concentrations are maintained in part by heme degradation, which is catalyzed by heme oxygenase. Heme oxygenase consists of two structurally related isozymes, HO-1 and HO-2. Recent studies have identified HO-2 as a potential oxygen sensor. To gain further insights into the regulatory role of HO-2 in heme homeostasis, we analyzed the expression profiles of HO-2 and the biochemical consequences of HO-2 knockdown with specific short interfering RNA (siRNA) in human cells. Both HO-2 mRNA and protein are expressed in the eight human cancer cell lines examined, and HO-1 expression is detectable in five of the cell lines, including HeLa cervical cancer and HepG2 hepatoma. Down-regulation of HO-2 expression with siRNA against HO-2 (siHO-2) caused induction of HO-1 expression at both mRNA and protein levels in HeLa and HepG2 cells. In contrast, knockdown of HO-1 expression did not noticeably influence HO-2 expression. HO-2 knockdown prolonged the half-life of HO-1 mRNA twofold in HeLa cells. Transient transfection assays in HeLa cells revealed that the 4.5-kb human HO-1 gene promoter was activated with selective knockdown of HO-2 in a sequence-dependent manner. Moreover, HO-2 knockdown caused heme accumulation in HeLa and HepG2 cells only when exposed to exogenous hemin. HO-2 knockdown may mimic a certain physiological change that is important in the maintenance of cellular heme homeostasis. These results suggest that HO-2 may down-regulate the expression of HO-1, thereby directing the co-ordinated expression of HO-1 and HO-2.

UI MeSH Term Description Entries
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006418 Heme The color-furnishing portion of hemoglobin. It is found free in tissues and as the prosthetic group in many hemeproteins. Ferroprotoporphyrin,Protoheme,Haem,Heme b,Protoheme IX
D006419 Heme Oxygenase (Decyclizing) A mixed function oxidase enzyme which during hemoglobin catabolism catalyzes the degradation of heme to ferrous iron, carbon monoxide and biliverdin in the presence of molecular oxygen and reduced NADPH. The enzyme is induced by metals, particularly cobalt. Haem Oxygenase,Heme Oxygenase,Oxygenase, Haem,Oxygenase, Heme
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D051547 Heme Oxygenase-1 A ubiquitous stress-responsive enzyme that catalyzes the oxidative cleavage of HEME to yield IRON; CARBON MONOXIDE; and BILIVERDIN. Hemeoxygenase 1,Heme Oxygenase 1,Oxygenase-1, Heme
D019169 Jurkat Cells A CELL LINE derived from human T-CELL LEUKEMIA and used to determine the mechanism of differential susceptibility to anti-cancer drugs and radiation. Cell, Jurkat,Cells, Jurkat,Jurkat Cell
D020014 K562 Cells An ERYTHROLEUKEMIA cell line derived from a CHRONIC MYELOID LEUKEMIA patient in BLAST CRISIS. Cells, K562

Related Publications

Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
December 2011, Iranian journal of medical sciences,
Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
October 2002, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation,
Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
December 2015, Forensic science, medicine, and pathology,
Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
February 2012, Fish & shellfish immunology,
Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
September 1998, Cell biochemistry and function,
Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
January 2015, European journal of medicinal chemistry,
Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
August 2023, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society,
Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
August 2008, Journal of leukocyte biology,
Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
June 1996, Blood,
Yuanying Ding, and Yong Z Zhang, and Kazumichi Furuyama, and Kazuhiro Ogawa, and Kazuhiko Igarashi, and Shigeki Shibahara
March 2017, AIDS (London, England),
Copied contents to your clipboard!